Fundamentals of Early Clinical Drug Development : From Synthesis Design to Formulation
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
Item type | Current library | Call number | Status | Notes | Date due | Barcode |
---|---|---|---|---|---|---|
![]() |
RAJUVAS Library | LZ3 SYN 2006 (Browse shelf(Opens below)) | Available | pharma 1003 | 184473 |
Browsing RAJUVAS Library shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | ||||||
LZ3 STE 2013 High-throughput screening methods in toxicity testing | LZ3 STO;1952 Arithmetic of Pharmacy / | LZ3 STR 2012 Pharmacoepidemiology | LZ3 SYN 2006 Fundamentals of Early Clinical Drug Development : | LZ3 SZA;1991 Adrenceptors: Structure, Mechanisms, Function / | LZ3 TAN;1996 GABA: Receptors; Transporters and Metabolism / | LZ3 TOL;1955 Ionic Interpretation of Drug Action in chemotherapeutic Research / |
An informative look at the intricacies of today's drug development process Once a discovery organization has identified a potential new drug candidate, it is the daunting task of synthetic organic chemists to identify the chemical process suitable for preparation of this compound in a highly regulated environment
Reflections on process research II / Edward J.J. Grabowski --
Development and scale-up of a heterocyclic cross-coupling for the synthesis of 5-(2-(3-methyl-3H-imidazol-4-yl)thieno(3,2-b)pyridin-7-yl)amino-2-methyl-1H-indol / John A. Ragan --
Large-scale enantioselective preparation of 2E,7E, 5S,6R, 5-hydroxy-6-methyl-8-phenyl-octa-2,7-dienoic acid, a key fragment for the formal total synthesis of the anti-tumor agent cryptophycin 52 / James Aikins ... [et al.] --
Efforts toward a commercially viable route and process to the synthesis of HIV PI GW640385X / John C. Roberts ... [et al.] --
Development of an asymmetric synthesis of ABT-100 / Albert W. Kruger ... [et al.] --
Asymmetric hydrogenation: a new route to pregabalin / Rex Jennings ... [et al.] --
Responsibilities of the process chemist: beyond synthetic organic chemistry / Stéphane Caron --
Outsourcing: the challenge of science, speed, and quality / Simone Andler-Burzlaff, Jason Bertola, and Roger E. Marti --
Automation and the changing face of process research in the pharmaceutical industry / Edward J. Delaney ... [et al.] --
Large scale synthesis: an engineering perspective / Joseph H. Childers, Jr. --
Synthesis and application of radioisotopes in pharmaceutical research and development / Larry E. Weaner and David C. Hoerr --
Selection of the drug form in exploratory development / George J. Quallich --
Strategies to control particle size of active pharmaceutical ingredients / David J. am Ende and Peter R. Rose --
Challenges in early formulation: turning drug substance into drug product / Mark H. Kleinman and Beeah Lee --
Intellectual property and early development / Maria I. Shchuka.
There are no comments on this title.